Answer
Kidney function affects prescribing and monitoring, especially for the intravenous formulation because its cyclodextrin vehicle can accumulate. The products are not recommended in end-stage renal disease.
Sources for this answer
- Quofenix 450 mg tablets — Current selected SmPCemc · Summary of Product Characteristics
- Quofenix 300 mg powder for concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics